Late non-fasting plasma glucose predicts cardiovascular mortality independent of hemoglobin A1c
- PMID: 35545695
- PMCID: PMC9095589
- DOI: 10.1038/s41598-022-12034-6
Late non-fasting plasma glucose predicts cardiovascular mortality independent of hemoglobin A1c
Abstract
It is unknown whether non-fasting plasma glucose (PG) is associated with cardiovascular disease (CVD) mortality. This study aimed to investigate this association in US adults. This study included adults from the National Health and Nutrition Examination Surveys from 1988 to 2014. Mortality outcomes were ascertained by linkage to the National Death Index records. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of PG for CVD mortality. Among 34,907 participants, 1956, 5564, and 27,387 had PG from participants in early non-fasting, late non-fasting, and fasting states, respectively (defined as a period since last calorie intake of 0-2.9, 3.0-7.9, or ≥ 8.0 h, respectively). This cohort was followed up for 455,177 person-years (mean follow-up, 13.0 years), with 2,387 CVD deaths being recorded. After adjustment for all confounders including hemoglobin A1c (HbA1c), only late non-fasting PG (continuous, natural log-transformed) was positively associated with CVD mortality risks (hazard ratio, 1.73; 95% confidence interval 1.12-2.67). Higher late non-fasting PG (dichotomous, at a cut-off of 105, 110, or 115 mg/dL) was associated with higher CVD mortality risks. In addition, at the cut-off of 115 mg/dL, higher late non-fasting PG was associated with higher CVD mortality risks in those with either a normal (< 5.7%) or prediabetic HbA1c level (from 5.7 to 6.4%). In conclusion, late non-fasting PG predicts CVD mortality independent of HbA1c. Late non-fasting PG with a cut-off of 115 mg/dL may be used to identify those at high CVD risk.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Fasting triglycerides are positively associated with cardiovascular mortality risk in people with diabetes.Cardiovasc Res. 2023 May 2;119(3):826-834. doi: 10.1093/cvr/cvac124. Cardiovasc Res. 2023. PMID: 35905014 Free PMC article.
-
Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A1c on Risk of Diabetes and Complications in Chinese Adults.Diabetes Care. 2019 Aug;42(8):1539-1548. doi: 10.2337/dc18-1390. Epub 2019 May 31. Diabetes Care. 2019. PMID: 31152120
-
Prediabetes Phenotypes and All-Cause or Cardiovascular Mortality: Evidence From a Population-Based Study.Endocr Pract. 2025 Apr;31(4):486-493. doi: 10.1016/j.eprac.2025.01.003. Epub 2025 Jan 19. Endocr Pract. 2025. PMID: 39837477
-
The U-shaped association of fasting plasma glucose to HbA1c ratio with mortality in diabetic and prediabetic populations: the mediating role of systemic immune-inflammation index.Front Endocrinol (Lausanne). 2025 Jan 27;16:1465242. doi: 10.3389/fendo.2025.1465242. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 39931237 Free PMC article.
-
1-h post-load plasma glucose for detecting early stages of prediabetes.Diabetes Metab. 2022 Nov;48(6):101395. doi: 10.1016/j.diabet.2022.101395. Epub 2022 Sep 29. Diabetes Metab. 2022. PMID: 36184047 Review.
Cited by
-
Postprandial Plasma Glucose between 4 and 7.9 h May Be a Potential Diagnostic Marker for Diabetes.Biomedicines. 2024 Jun 13;12(6):1313. doi: 10.3390/biomedicines12061313. Biomedicines. 2024. PMID: 38927521 Free PMC article.
-
Dietary fatty acids and mortality risk from heart disease in US adults: an analysis based on NHANES.Sci Rep. 2023 Jan 28;13(1):1614. doi: 10.1038/s41598-023-28738-2. Sci Rep. 2023. PMID: 36709394 Free PMC article.
-
Fasting Triglycerides in the Upper Normal Range Are Independently Associated with an Increased Risk of Diabetes Mortality in a Large Representative US Population.J Cardiovasc Dev Dis. 2024 Apr 21;11(4):128. doi: 10.3390/jcdd11040128. J Cardiovasc Dev Dis. 2024. PMID: 38667746 Free PMC article.
-
Postprandial Plasma Glucose Measured from Blood Taken between 4 and 7.9 h Is Positively Associated with Mortality from Hypertension and Cardiovascular Disease.J Cardiovasc Dev Dis. 2024 Feb 4;11(2):53. doi: 10.3390/jcdd11020053. J Cardiovasc Dev Dis. 2024. PMID: 38392267 Free PMC article.
-
Fasting triglycerides are positively associated with cardiovascular mortality risk in people with diabetes.Cardiovasc Res. 2023 May 2;119(3):826-834. doi: 10.1093/cvr/cvac124. Cardiovasc Res. 2023. PMID: 35905014 Free PMC article.
References
-
- Barr EL, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Circulation. 2007;116:151–157. doi: 10.1161/CIRCULATIONAHA.106.685628. - DOI - PubMed
-
- Arnett DK, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2019;74:e177–e232. doi: 10.1016/j.jacc.2019.03.010. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical